4,5,6,7-tetrabromobenzotriazole,
TBB benzotriazole,
17374-26-4,
4,5,6,7-tetrabromobenzotriazole,
TBB,
4,5,6,7-Tetrabromo-1H-benzotriazole,
TBBt,
4,5,6,7-Tetrabromo-2-azabenzimidazole,
CK2 Inhibitor,
4,5,6,7-Tetrabromo-1H-benzo[d][1,2,3]triazole,
Casein Kinase II Inhibitor I,
4,5,6,7-tetrabromo-2H-benzotriazole,
TETRABROMO-2-BENZOTRIAZOLE,
NSC 231634,
CHEMBL177820,
MFCD06411399,
NSC231634,
InSolution™ Casein Kinase II Inhibitor I,
TBB;TBBT,
1p5e,
C6HBr4N3,
SCHEMBL263343,
AC1L1C10,
AC1Q25E8,
GTPL9372,
STO170,
SCHEMBL16463781,
BDBM11323,
CTK4D4758,
KS-00000NUG,
AOB1747,
DTXSID20274322,
OMZYUVOATZSGJY-UHFFFAOYSA-N,
HMS2043P01,
HMS3229D01,
HMS3262L12,
HMS3268H06,
HMS3677A16,
BCP04100,
ZINC3870968,
TBB (NSC 231634),
TBB, >=98% (HPLC), solid,
Tox21_500935,
4086AH,
BS0193,
HSCI1_000172,
AKOS015951304,
AKOS026750603,
CCG-222239,
CS-1079,
DB04462,
FCH1378202,
LP00935,
NSC-231634,
1H-Benzotriazole,4,5,6,7-tetrabromo-,
NCGC00092352-01,
NCGC00092352-02,
NCGC00092352-03,
NCGC00092352-04,
NCGC00261620-01,
1H-Benzotriazole, 4,5,6,7-tetrabromo-,
4CA-1217,
AJ-46340,
AK-64086,
AS-16678,
HY-14394,
BCP0726000105,
AB0071659,
AB1009168,
TX-017978,
FT-0674939,
ST24042566,
TBB;1H-Benzotriazole,4,5,6,7-tetrabromo-,
4,5,6,7-tetrabromo-1h-1,2,3-benzotriazole,
K00040,
W-5331,
177518-EP2280011A1,
1H-1,2,3-benzotriazole, 4,5,6,7-tetrabromo-,
J-010940,
BRD-K97118047-001-01-2,
BRD-K97118047-001-02-0,
BRD-K97118047-001-03-8,
NSC-231634|||4,5,6,7-Tetrabromo-2H-benzotriazole,
4,5,6,7-Tetrabromo-2-azabenzimidazole; 4,5,6,7-Tetrabromobenzotriazole; TBBt,
TBB benzotriazole,
tetraBr-1-azaBz,
D0O1YH,
CID1694,
AR-1F8208,
ACN-051498,
A3861,
T2920,
A15257,
C103118,
C405354,
TBS,
1774-11-4,
4,5,6,7-Tetrabromobenzotriazole, 97%, selective, cell-permeable casein kinase-2 (CK2) inhibitor - 250MG 250mg,